Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

por Medhat, Arvin, Arzumanyan, Alla, Feitelson, Mark A.
Publicado 2021

Editorial: Microbiome metabolites in health and disease

por Canfora, Emanuel E., Feitelson, Mark A., Arzumanyan, Alla
Publicado 2023

Short-chain fatty acids in cancer pathogenesis

por Feitelson, Mark A., Arzumanyan, Alla, Medhat, Arvin, Spector, Ira
Publicado 2023

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B

por Feitelson, Mark A., Arzumanyan, Alla, Spector, Ira, Medhat, Arvin
Publicado 2022

Correction: UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1 or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines

por Wu, Guoyi, Xu, Linan, Lin, Nan, Liu, Bo, Feitelson, Mark A
Publicado 2014

Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice

por McBrearty, Noreen, Arzumanyan, Alla, Bichenkov, Eugene, Merali, Salim, Merali, Carmen, Feitelson, Mark
Publicado 2021

Epigenetic repression of E-cadherin expression by Hepatitis B virus x Antigen (HBx) in liver cancer

por Arzumanyan, Alla, Friedman, Tiffany, Kotei, Enoch, Ng, Irene O.L., Lian, Zhaorui, Feitelson, Mark A.
Publicado 2011

Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma

por Yuan, Ke, Lian, Zhaorui, Sun, Bill, Clayton, Marcia M., Ng, Irene O. L., Feitelson, Mark A.
Publicado 2012

Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses

por Liu, Xiaohong, Wang, Li, Zhang, Shuhui, Lin, Jing, Zhang, Shunmin, Feitelson, Mark A., Gao, Hengjun, Zhu, Minghua
Publicado 2008

A Spiroligomer α-Helix Mimic That Binds HDM2, Penetrates Human Cells and Stabilizes HDM2 in Cell Culture

por Brown, Zachary Z., Akula, Kavitha, Arzumanyan, Alla, Alleva, Jennifer, Jackson, Marcus, Bichenkov, Eugeney, Sheffield, Joel B., Feitelson, Mark A., Schafmeister, Christian E.
Publicado 2012

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator

por Hurwitz, Selwyn J., McBrearty, Noreen, Arzumanyan, Alla, Bichenkov, Eugene, Tao, Sijia, Bassit, Leda, Chen, Zhe, Kohler, James J., Amblard, Franck, Feitelson, Mark A., Schinazi, Raymond F.
Publicado 2021